Convergent loss of PTEN leads to clinical resistance to a PI3Ka inhibitor
Excerpt:
Targeted exome sequencing identified homozygous loss of PTEN in a post-treatment sample of a breast cancer patient who developed resistance to BYL719 after initially experiencing a durable response to therapy.